Chronic Kidney Disease Nutritional Supplement Market
According to the USD Analytics published latest research report, the global “Chronic Kidney Disease Nutritional Supplement Market” is expected to grow at a tremendous CAGR of 4.3% during the forecast period 2023-2030.
Nutrition is critical to the outcome of chronic kidney disease (CKD). In many circumstances, there is a link between nutrition and chronic renal disease; nutritional supplements aid in-patient rehabilitation. For example, micronutrients such as salt and phosphorus are essential components of dietary supplements and are increasingly favored over chronic kidney disease (CKD) medicines. Amino acid supplements, vitamin and mineral supplements, probiotics, prebiotics/fibers, and herbal supplements are all part of advanced chronic renal disease nutrition. Some health problems caused by chronic kidney disease may be avoided or delayed by eating the correct meals and avoiding foods heavy in salt, potassium, and phosphorus.
Browse Full Report @ https://www.usdanalytics.com/industry-reports/chronic-kidney-disease-nutritional-supplement-market
Market Drivers:
The global chronic kidney disease nutritional supplements market is being driven by an increase in the geriatric population, an increase in the incidence of chronic kidney disease (CKD), an increase in the use of medicinal food supplements for chronic renal failure, and an increase in sales via e-commerce platforms. The global senior population is growing. Chronic ailments like chronic renal disease are more common in this group. According to the United Nations World Population Ageing 2019 report, 703 million people were 65 or older in the world in 2019, which is expected to quadruple to 1.5 billion by 2050. According to new estimates from Johns Hopkins University researchers, more than half of those over 75 have a renal illness. Kidney disease has also been discovered to be more common in those over 60 than in the general population.
Covid-19 Impact Analysis:
COVID-19 has increased the global chronic renal disease nutritional supplement size. The unusual COVID-19 epidemic has mostly afflicted nations in North America and Europe, including the United States, Italy, Spain, the United Kingdom, France, and Germany. These areas have a high concentration of the dietary supplement sector. The pandemic crisis has helped the industry since there has been an increase in demand for immunity-boosting products. Immunity-boosting vitamins, minerals, and herbs saw a rise in demand in 2020, and this trend is projected to continue until the COVID-19 vaccine is available to everyone. The proliferation of COVID-19 has increased customer traffic to complete e-commerce platforms, resulting in customers’ easy access to various supplement brands. Consumers’ online shopping habits acquired during the epidemic are predicted to persist in the coming years.
Recent Industry Developments:
- Mankind Pharma Ltd. launched the Health OK multivitamin pill and dietary supplement in March 2021. This substance aids in the treatment of modern-day lifestyle disorders. It contains natural ginseng and taurine formulations for energy maintenance, 20 multivitamins and minerals for total health improvement, and vitamins C, D, and zinc for immunity strengthening. The Health OK pill replenishes the body’s necessary vitamins and minerals and aids in healing wounds, boosting the immune system, mending free radical-damaged cells, strengthening bones, and turning food into energy.
- Following permission from antitrust regulators in the United States, Fresenius SE & Co. KGaA finalized the purchase of NxStage Medical, Inc. (NxStage) in February 2019. NxStage manufactures, develops, and distributes medical equipment for home dialysis and critical care settings. Fresenius Medical Care could use its manufacturing, supply chain, and marketing capabilities across dialysis products, services, and care coordination companies in less labor- and capital-intensive care environment as a result of the purchase.
Segmentation Analysis:
As per the research an analysis, the global chronic kidney disease nutritional supplement market is segmented by nutrition type into amino acid supplements, vitamin & mineral supplements, probiotics, prebiotics / fibers, and others; by dosage form into capsule, liquid, powder, and others; by FSMP mode of administration into oral nutrition (ON), and enteral nutrition (EN); by CKD stage into pre-dialysis stage 1-2, pre-dialysis stage 3-5, dialysis, and end-stage renal disease; and by distribution channel into hospital pharmacies, retail pharmacies, and online stores.
Based on dosage form the global chronic kidney disease nutritional supplement market has been segmented into capsule, liquid, powder, and others. The capsule dosage type represented the highest proportion of the global chronic renal disease nutritional supplement market in 2022. The current trend is expected to continue over the predicted period. This may be attributed to the increased adoption of capsules over alternative dosage forms since they are simpler to swallow, more convenient, and have better-perceived efficiency and more market availability.
Download Sample Report @ https://www.usdanalytics.com/sample-request/7425
Geographical Analysis:
The global chronic kidney disease nutritional supplement market is segmented into North America, Europe, South America, Asia Pacific, and Middle East & Africa.
North America Chronic Kidney Disease Nutritional Supplement Market
North America had the highest share of the global chronic renal disease nutritional supplement market in 2022. The current trend is projected to continue during the projection period. The prominent competitors, favorable reimbursement policies, and well-established healthcare infrastructure contribute to the region’s market growth.
Asia Pacific Chronic Kidney Disease Nutritional Supplement Market
Asia Pacific is expected to grab the greatest share of the global market over the projected period due to a growth in the senior population, a bigger CKD patient population base, expanding healthcare infrastructure, and an increase in diabetes prevalence. Due to high population density, leading multinational firms’ desire to increase their production bases and product range in Asia and Southeast Asia nations such as South Korea, Malaysia, India, and China is likely to boost the market in the region over the forecast period.
According to the United Nations Population Fund (UNFPA), by 2050, one in every four individuals in Asia and the Pacific will be beyond the age of 60. Between 2010 and 2050, the region’s population of senior people (those over 60) will treble, reaching about 1.3 billion.
Avail Discount on purchasing full report @ https://www.usdanalytics.com/discount-request/7425
Competitive Landscape:
The key players contributing to the global chronic kidney disease nutritional supplement market growth include abbott laboratories, ajanta pharma limited, fresenius kabi AG, hexagon nutrition limited, mankind pharma Ltd., nestlé S.A., nutricia limited (Danone S.A.), PRINE Health MSO, LLC, RPG Life Sciences Limited.
Related Reports:
Polycystic Kidney Disease Market Segmented By Type (Autosomal Dominant Polycystic Kidney Disease, Autosomal Recessive Polycystic Kidney Disease, Others), Treatment (Medication, Surgery, Others), Diagnosis (Ultrasound, CT Scan, MRI Scan), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
Nephrology And Urology Devices Market Size, Share, Trends, Growth Outlook and Opportunities to 2030-by Type (Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, Others), by Application (Urolithiasis, Urological Cancer & BPH, Bladder Disorders, Kidney Diseases, Others), by End-Use (Hospitals, Clinics, Ambulatory Surgical Centers, Others), and Companies Report
Media Contact
Company Name: USD Analytics
Contact Person: Harry James
Email: Send Email
Phone: +1 213-510-3499
Country: India
Website: https://www.usdanalytics.com/industry-reports/chronic-kidney-disease-nutritional-supplement-market